Who has been buying Mujin Medi stock?

1 distinct insiders have filed 20 disclosed insider purchases in Mujin Medi (322970), most recently on 2025-01-01. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Mujin Medi have?

Mujin Medi has 20 buy-side and 0 sell-side disclosures on record, covering ₩48M ($33K) in total reported value, spanning 2024-01-10 to 2025-01-01.

Where does StockDrifts get Mujin Medi insider data?

From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Mujin Medi 322970

Company

무진메디Mujin Medi

Insiders

Buys

Total Value

₩48M ($33K)

Avg Return

+1.05%

Last Filing

2025-01-01

Mujin Medi (322970) has 20 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩48M ($33K) in reported transaction value. The earliest filing StockDrifts holds for Mujin Medi is dated 2024-01-10; the most recent is 2025-01-01. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +1.05%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2025-01-01	BUY	신규선임	김진현 Jinhyun Kim	moving	6.1K	₩2,440	-18.3%	₩15M ($10K)
2024-08-29	BUY	Market Buy	윤태종 Taejong Yoon	CEO	1.8K	₩1,660	+20.1%	₩3M ($2K)
2024-08-28	BUY	Market Buy	윤태종 Taejong Yoon	CEO	100	₩1,620	+23.1%	₩162K ($113)
2024-08-27	BUY	Market Buy	윤태종 Taejong Yoon	CEO	300	₩1,658	+20.3%	₩497K ($345)
2024-08-26	BUY	Market Buy	윤태종 Taejong Yoon	CEO	330	₩1,584	+25.9%	₩523K ($363)
2024-08-23	BUY	Market Buy	윤태종 Taejong Yoon	CEO	34	₩1,624	+22.8%	₩55K ($38)
2024-08-21	BUY	Market Buy	윤태종 Taejong Yoon	CEO	299	₩1,784	+11.8%	₩533K ($370)
2024-08-20	BUY	Market Buy	윤태종 Taejong Yoon	CEO	455	₩1,747	+14.1%	₩795K ($552)
2024-08-16	BUY	Market Buy	윤태종 Taejong Yoon	CEO	745	₩1,757	+13.5%	₩1M ($909)
2024-08-14	BUY	Market Buy	윤태종 Taejong Yoon	CEO	110	₩1,749	+14.0%	₩192K ($134)
2024-08-12	BUY	Market Buy	윤태종 Taejong Yoon	CEO	1.1K	₩1,848	+7.9%	₩2M ($1K)
2024-08-04	BUY	Market Buy	윤태종 Taejong Yoon	CEO	1.0K	₩1,939	+2.8%	₩2M ($1K)
2024-08-03	BUY	Market Buy	윤태종 Taejong Yoon	CEO	2.7K	₩1,939	+2.8%	₩5M ($4K)
2024-08-02	BUY	Market Buy	윤태종 Taejong Yoon	CEO	1.8K	₩2,170	-8.1%	₩4M ($3K)
2024-08-01	BUY	Market Buy	윤태종 Taejong Yoon	CEO	9.1K	₩2,180	-8.5%	₩20M ($14K)
2024-07-31	BUY	Market Buy	윤태종 Taejong Yoon	CEO	1.0K	₩2,060	-3.2%	₩2M ($1K)
2024-02-19	BUY	Market Buy	윤태종 Taejong Yoon	CEO	709	₩2,750	-27.5%	₩2M ($1K)
2024-02-16	BUY	Market Buy	윤태종 Taejong Yoon	CEO	350	₩2,700	-26.1%	₩945K ($656)
2024-02-15	BUY	Market Buy	윤태종 Taejong Yoon	CEO	939	₩2,765	-27.9%	₩3M ($2K)
2024-02-08	BUY	Market Buy	윤태종 Taejong Yoon	CEO	1	₩2,620	-23.9%	₩3K ($2)
2024-01-10	BUY	Market Buy	윤태종 Taejong Yoon	CEO	1	₩2,975	-33.0%	₩3K ($2)

Frequently asked questions

Who has been buying Mujin Medi stock?: 1 distinct insiders have filed 20 disclosed insider purchases in Mujin Medi (322970), most recently on 2025-01-01. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Mujin Medi have?: Mujin Medi has 20 buy-side and 0 sell-side disclosures on record, covering ₩48M ($33K) in total reported value, spanning 2024-01-10 to 2025-01-01.
Where does StockDrifts get Mujin Medi insider data?: From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Mujin Medi. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.